The CMMC provides various innovative measures to support research groups at the UoC working in the areas of molecular medicine, to attract new talents with specific programs and to educate scientists at all levels of their career. These funding programs have been essential for the CMMC to achieve its goal of better promoting high-quality biomedical research as well as supporting the career paths of young scientists and clinicians.
The CMMC provides the following seven different funding programs that support clinicians and researchers at different stages and settings of their education and scientific academic career:
The IPMM is aimed at early stage research-oriented physicians and postgraduate natural scientists and is designed to provide doctoral candidates with a comprehensive range of relevant and timely training to better promote his/her career in the field of molecular biomedical research.
The CMMC’s BGP facilitates the ad hoc recruitment of excellent scientists by providing immediate support for pertaining clinical departments or institutes in cases of budget shortage. The advantage of this program is that it avoids time-consuming recruitment procedures, thereby enabling competitive international headhunting.
Since the CMMC’s foundation in 1994 the JRGP has been an integral part of its support measures for junior researchers’ careers. Currently the Center provides funding for three internationally competitive JRGs, which is comparable to the Emmy Noether-Program by the DFG and equivalent to an Assistant Professorship (W1) with a running period of 5 (+3) years.
The recently established Career Advancement Program (CAP) is a funding instrument that has been specifically designed to support high-potential mid-career scientists of the Medical Faculty aiming for professorships or equivalent leadership positions at non-university research institutions. Currently the CMMC supports 9 CAP-groups.
To ensure that young physicians have enough time to devote to their research endeavors, the CMMC provides up to three rotating positions for young physician scientists to withdraw from clinical tasks and responsibilities and to spend more time on their research. The RPP has proved to be highly successful in allowing physician scientists to focus on and advance their research.
This program benefits from the CMMC´s dynamic allocation concept of lab/research space in the CMMC Research Building. For example, the Center integrates research groups funded by external institutions as associated research groups and provides access to lab/research space, core untis and support from the Central Office.
The support of individual projects has been a cornerstone of CMMC policy from the beginning. The aim of the CMMC is to provide funding for the development of long-term, high risk, high quality, innovative biomedical projects that demonstrate a clear disease-oriented focus having clinical impact. This highly competitive research fund strictly correlates to the three-year funding period of the Center.
In January 2017 the CMMC started the 8th funding period with arunning period o three years.
The preparation of the 9th funding period has been initiated by the announcement for submitting research proposals for this program in spring 2019. Eligble applicants, whose research proposals receive "the recommendation for funding" after the internal/external evaluation process including the site visit of the External Advisory Board on Nov. 25-26, 2019 are the principal investigator of the IPFP for the new funding period (01/2020 – 12/2019).
Currently the CMMC supports 33 individual projects of scientists/clinician scientists who are leading a research group in departments and institutes of the Faculty of Medicine and the Facutly of Mathematics and Natural Sciences.
The CMMC has provided support since 2008 to outstanding, officially retired senior scientists, who demonstrate a sustained high level of productivity and whose expertise and research accomplishments have been and will continue to be crucial to the CMMC. In line with this, the CMMC awarded Professor Wilhelm Stoffel (Emeritus, Lab. for Molecular Neurobiology) a SRG Leader position for the current funding period 2017 - 2019.